Histone H3 lysine 18 lactylation attenuates neuroinflammation and neurological damage by regulating microglial plxnb2

Ping Li1, Yao Wang1, Yuan Xu1

  • 1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030 Wuhan, China.

Neurobiology of Disease
|August 20, 2025
PubMed

Insights

Histone lactylation in microglia reduces brain damage after ischemic stroke. Targeting this pathway, specifically histone H3 lysine 18 lactylation (H3K18la) and plxnb2, offers a novel therapeutic approach for stroke recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Microglia are key immune cells in the central nervous system, crucial in ischemic stroke pathogenesis.
  • Histone lactylation influences macrophage gene expression and immune responses, but its role in stroke is unclear.

Purpose of the Study:

  • To investigate the role and expression of histone lactylation in microglia following ischemic stroke.
  • To elucidate the molecular mechanisms underlying histone lactylation's effects on neurological injury.

Main Methods:

  • Induction of focal cerebral ischemia using middle cerebral artery occlusion in mice.
  • Assessment of histone lactylation levels in peri-infarct areas.
  • Microglia-specific inhibition of plxnb2 to evaluate its role in neuroprotection.

Main Results:

  • Increased histone lactylation observed in peri-infarct regions post-stroke.
  • Enhanced histone lactylation promoted an anti-inflammatory environment and neuroprotection.
  • Histone H3 lysine 18 lactylation (H3K18la) mediated plxnb2 expression in microglia, crucial for neuroprotection.

Conclusions:

  • Histone lactylation, particularly H3K18la, plays a neuroprotective role in ischemic stroke by modulating microglial activity.
  • The lactate/lactylation(H3K18la)/plxnb2 axis represents a potential therapeutic target for treating ischemic stroke.